ストックスクリーナーアプリを入手
0.9598
1.04%
-0.0101
Unity Biotechnology Inc (UBX) 最新ニュース
Unity Biotechnology stock hits 52-week low at $0.95 - Investing.com
Unity Biotechnology (NASDAQ:UBX) Trading Down 5.6% – What’s Next? - Defense World
Unity Biotechnology stock hits 52-week low at $1.1 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.1 By Investing.com - Investing.com UK
Unity Biotechnology stock hits 52-week low at $1.1 amid challenges - Investing.com Canada
Unity Biotechnology (FRA:9U90) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
Unity Biotechnology (STU:9U90) EV-to-Revenue : (As of Nov. 28, 2024) - GuruFocus.com
Finance Watch: Adcendo Pursues Proof-Of-Concept With $135m Series B Round - Citeline
Unity Biotechnology (FRA:9U90) Price-to-Operating-Cash-Flow : (As of Nov. 25, 2024) - GuruFocus.com
Frazier Life Sciences Appoints John Smither and Jim Williams as Senior Advisors - BioSpace
Alyeska Investment Group L.P.'s Strategic Acquisition in Unity B - GuruFocus.com
Carisma Therapeutics (NASDAQ:CARM) vs. Unity Biotechnology (NASDAQ:UBX) Head-To-Head Comparison - Defense World
Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews
Unity Biotechnology's CFO sells shares worth $175 - Investing.com India
Unity Biotechnology's chief legal officer sells shares worth $192 - Investing.com India
Unity Biotechnology's CFO sells shares worth $175 By Investing.com - Investing.com Canada
Unity Biotechnology's chief legal officer sells shares worth $192 By Investing.com - Investing.com Canada
Unity Biotechnology stock hits 52-week low at $1.15 - Investing.com
Unity Biotechnology stock hits 52-week low at $1.15 By Investing.com - Investing.com Canada
Is Unity Biotechnology (NASDAQ:UBX) In A Good Position To Invest In Growth? - Simply Wall St
Unity Biotechnology Focuses on Promising DME Treatment - TipRanks
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024 - The Manila Times
UNITY Biotechnology, Inc. Reports Third Quarter 2024 Financial Results and Business Updates - GlobeNewswire
Age-related Macular Degeneration Market Size is Set for Rapid - openPR
Wet Age-Related Macular Degeneration Pipeline Therapeutics, Assessment, Companies, Products, Unmet Needs, Market Drivers and Barriers - The Globe and Mail
Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals - Yahoo Finance UK
First patient dosed at the Tokyo Medical Center by Belite Bio in Phase 2/3 DRAGON II clinical trial - Ophthalmology Times
Empery Asset Management, LP Acquires Shares in Volcon Inc - Yahoo Finance UK
Empery Asset Management's Strategic Acquisition in Elevation Oncology - Yahoo Finance
Empery Asset Management's Strategic Reduction in Sharps Technology Inc - Yahoo Finance
To Reverse Aging’s Clock, Adjust the Cell’s Machinery - Genetic Engineering & Biotechnology News
UNITY Biotechnology to Host In-Person Ophthalmology Day in New York on Tuesday, October 15, 2024 - GlobeNewswire
Unity Biotechnology (FRA:9U90) Cash Ratio : 3.85 (As of Jun. 2024) - GuruFocus.com
Jefferies Financial Group Boosts United Therapeutics (NASDAQ:UTHR) Price Target to $432.00 - Defense World
Tri Locum Partners LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - MarketBeat
Epoch Investment Partners Inc. Increases Stake in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
United Therapeutics Co. (NASDAQ:UTHR) Shares Acquired by Mercer Global Advisors Inc. ADV - Defense World
Symmetry Investments LP Makes New Investment in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
American Century Companies Inc. Has $13.14 Million Position in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Pacer Advisors Inc. Grows Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Meiji Yasuda Asset Management Co Ltd. Buys 33 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Longevity and Anti-Senescence Therapy Market Share, Size, Growth, and Forecast to 2031 - InsightAce Analytic
Inspire Investing LLC Acquires 2,936 Shares of United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Uniti Group Inc [UNIT] stock was sold by Mudry Ronald J. at the price of US$0.11 million - Knox Daily
1,054 Shares in United Therapeutics Co. (NASDAQ:UTHR) Bought by Choreo LLC - Defense World
Quest Partners LLC Has $89,000 Stock Holdings in United Therapeutics Co. (NASDAQ:UTHR) - Defense World
Liquidia Corp faces renewed legal challenge from United Therapeutics By Investing.com - Investing.com Australia
Meeder Advisory Services Inc. Invests $36,000 in Uniti Group Inc. (NASDAQ:UNIT) - Defense World
Unity Software Inc. (NYSE:U) Shares Bought by Daiwa Securities Group Inc. - Defense World
Commonwealth Equity Services LLC Has $1.16 Million Position in Unity Software Inc. (NYSE:U) - Defense World
Court rules against United Therapeutics in Liquidia case - Investing.com India
Royal London Asset Management Ltd. Boosts Stake in Unity Software Inc. (NYSE:U) - Defense World
694 Shares in United Therapeutics Co. (NASDAQ:UTHR) Purchased by Caprock Group LLC - Defense World
Anti-Senescence Therapy Market is Likely to Upsurge at USD 25.16 Bn- Unity Biotechnology, OisinBiotechnologies, AgeX Therapeutics, Siwa – Daily News Mirror - Daily News Mirror
The Top 8 Things to Know About Anti-Aging Research Right Now - upworthyscience.com
UBX (Unity Biotechnology) Debt-to-Equity : 1.10 (As of Jun. 2024) - GuruFocus.com
Billionaires are spending big so they — and maybe you — can live forever - MarketWatch
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):